Pleural Dynamics, Inc.
First-of-its-kind ACES implant to treat recurrent pleural effusions
About
Pleural Dynamics is a Minneapolis based medical device start-up focused on developing best in class solutions for chronic, recurrent fluid collections within the body. Our flagship product, ACES (the Automatic Continuous Effusion Shunt), is designed for the treatment of chronic recurrent pleural effusions. Chronic recurrent pleural effusions are a build-up of excess fluid between the lung and chest wall that compresses the lung and weighs on the diaphragm causing debilitating shortness of breath, irritating cough, poor quality of life, and short life expectancy. Recurrent pleural effusions affect approximately 660,000 new people in US and Europe each year and represents a $1.5B annual market opportunity for Pleural Dynamics. The current treatment options are cumbersome, costly, and based on decades old technology. ACES utilizes normal breathing motion to automatically pump pleural effusion fluid out of the chest and into the abdomen where it is quickly and safely reabsorbed by the body. This action provides continuous relief of patient symptoms while simultaneously decreasing caregiver labor, infection risk, and overall expense.
Product
- Value proposition
- FDA-cleared, minimally invasive implant that eliminates recurrent pleural effusions with simple, sustained relief
- Target customers
- Healthcare providers treating pleural effusion and hospitals/clinics
- Pricing
- Reimbursement guidance available; unspecified direct pricing
- Regulatory
- FDA-cleared; device approved for sale in USA
Founders
- Martin Mayse — CEO, Co-Founder
- John Streeter — CTO, Co-Founder
Categories
Products
Key features
Technologies
Integrations
Target conditions
Care settings
Certifications
Traction metrics
Competitors
Investors
News
- Pleural Dynamics Receives FDA 510(k) Clearance for its Novel ACES™ System - Pleural Dynamics · 2026-03-09T17:06:10.000Z
- The ACES Study for Aseptic Pleural Effusions - Pleural Dynamics · 2026-03-09T17:08:35.000Z
- Pleural Dynamics reports positive data for automatic effusion shunt · 2025-10-28T15:45:34.000Z
- Pleural Dynamics Announces Completion of Enrollment of “The ACES Study for Aseptic Pleural Effusions,” a Post Market Study Evaluating the Novel ACES Automatic Continuous Effusion Shunt System · 2025-08-19T14:00:00.000Z
- CMS Grants HCPCS Code and NTAP Classification for Pleural Dynamics’ Novel ACES Automatic Continuous Effusion Shunt · 2025-10-14T00:00:00.000Z
- Pleural Dynamics earns Medicare win for effusion shunt · 2025-10-14T15:10:28.000Z
More links
Browse similar startups
Related startups
- Pops — Oak Park Heights, MN
- Senphonix — Saint Paul, MN
- Serenity Behavioral Health & Wellness LLC — Savage, MN
- SUGAR LOAF SENIOR LIVING — Winona, MN
- Toothapps® — Wayzata, MN
- UPTOWN DERMATOLOGY AND SKIN SPA, P.A — Minneapolis, MN
- Plexis.ai (Techstars '25) — Delaware, DE
- Plinth Analytics — New York, NY
- Pluck Consulting Group — The Woodlands, TX
- PointHealth AI — San Francisco, CA
- Polso (formerly ChroniSense Medical) — Boston, MA
- Polygon Health Analytics LLC — Philadelphia
Profile updated Jul 29, 2026. Sources: pleuraldynamics.com, linkedin.com
